Related Experiment Video
Updated: May 8, 2026

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
Differential modulation of TREM2 protein during postnatal brain development in mice
Mariela Chertoff1, Kalpana Shrivastava, Berta Gonzalez
1Department of Cell Biology, Physiology and Immunology, Universitat Autonoma Barcelona, Barcelona, Spain ; Institute of Neuroscience, Universitat Autonoma Barcelona, Barcelona, Spain.
Abstract:
During postnatal development, microglia, the resident innate immune cells of the central nervous system are constantly monitoring the brain parenchyma, cleaning the cell debris, the synaptic contacts overproduced and also maintaining the brain homeostasis. In this context, the postnatal microglia need some control over the innate immune response. One such molecule recently described to be involved in modulation of immune response is TREM2 (triggering receptor expressed on myeloid cells 2). Although some studies have observed TREM2 mRNA in postnatal brain, the regional pattern of the TREM2 protein has not been described. We therefore characterized the distribution of TREM2 protein in mice brain from Postnatal day (P) 1 to 14 by immunostaining. In our study, TREM2 protein was expressed only in microglia/macrophages and is developmentally downregulated in a region-dependent manner. Its expression persisted in white matter, mainly in caudal corpus callosum, and the neurogenic subventricular zone for a longer time than in grey matter. Additionally, the phenotypes of the TREM2+ microglia also differ; expressing CD16/32, MHCII and CD86 (antigen presentation markers) and CD68 (phagocytic marker) in different regions as well as with different intensity till P7. The mannose receptor (CD206) colocalized with TREM2 only at P1-P3 in the subventricular zone and cingulum, while others persisted at low intensities till P7. Furthermore, the spatiotemporal expression pattern and characterization of TREM2 indicate towards its other plausible roles in phagocytosis, progenitor's fate determination or microglia phenotype modulation during postnatal development. Hence, the increase of TREM2 observed in pathologies may recapitulate their function during postnatal development, as a better understanding of this period may open new pathway for future therapies.
Insights
Triggering receptor expressed on myeloid cells 2 (TREM2) protein is developmentally downregulated in the postnatal mouse brain, with distinct regional patterns and microglial phenotypes, suggesting roles in homeostasis and potential therapeutic targets.
Area of Science:
- Neuroscience
- Immunology
- Developmental Biology
Background:
- Microglia, the brain's immune cells, maintain homeostasis and regulate immune responses during postnatal development.
- Triggering receptor expressed on myeloid cells 2 (TREM2) is implicated in immune modulation, but its protein distribution in the developing brain is unknown.
Purpose of the Study:
- To characterize the spatiotemporal distribution of TREM2 protein in the postnatal mouse brain.
- To investigate the phenotypic characteristics of TREM2-expressing microglia during early development.
Main Methods:
- Immunostaining of TREM2 protein in mouse brain tissue from postnatal day 1 to 14.
- Analysis of TREM2 co-localization with microglial markers (CD16/32, MHCII, CD86, CD68, CD206).
Main Results:
- TREM2 protein is exclusively expressed in microglia/macrophages and is developmentally downregulated in a region-dependent manner.
- TREM2 expression persists longer in white matter (corpus callosum) and the subventricular zone compared to grey matter.
- TREM2+ microglia exhibit region-specific expression of activation and phagocytic markers (CD16/32, MHCII, CD86, CD68) and mannose receptor (CD206).
Conclusions:
- The spatiotemporal pattern of TREM2 suggests roles beyond immune modulation, potentially in phagocytosis and progenitor cell fate during postnatal development.
- Understanding TREM2's developmental roles may offer new therapeutic strategies for neurological pathologies.
- TREM2's function during development may be recapitulated in disease states.

